文献速递神经MR

未治疗颅内脑膜瘤随访MRI真的需要对比剂吗?

Is Contrast Medium Really Needed for Follow-up MRI of Untreated Intracranial Meningiomas?
PubMed 文献 · AJNR Am J Neuroradiol · 2021-06-11

回顾性队列纳入122例患者共132个脑膜瘤,比较T1 3D-钆增强与2D-T2WI分割测量肿瘤体积、面积、径线及年生长速度的一致性。两种序列各项测量指标组内相关系数均很高(体积ICC=0.996),提示无对比剂MRI可能适用于未治疗脑膜瘤随访。

要点

  • T1 3D-钆增强与2D-T2WI分割脑膜瘤体积一致性极佳(ICC=0.996)。
  • 肿瘤年生长速度两种序列间亦呈良好一致性(P<.001)。
  • 作者认为无对比剂MRI可能适用于未治疗脑膜瘤随访。

核心结论

  • T1 3D-钆增强与2D-T2WI所得脑膜瘤大小和生长一致性极佳,提示无对比剂MRI可能适用于未治疗脑膜瘤随访,具有成本效益并可规避对比剂相关风险。

研究设计与样本

  • 回顾性队列研究,纳入2007年5月至2019年5月本院122例(男35、女87)脑膜瘤患者的132个脑膜瘤,所有肿瘤在T1 3D-钆增强与2D-T2WI上分割,以组内相关系数评价两种序列分割的一致性。

诊断标准与关键数值

  • T1 3D-钆增强与2D-T2WI分割一致性:平均肿瘤体积T1 3D-钆增强9012.15(SD 19,223.03)mm3 vs T2WI 8528.45(SD 18,368.18)mm3,ICC=0.996;表面积ICC=0.989;表面积/体积比ICC=0.924;最大3D直径ICC=0.986;轴位最大2D直径ICC=0.990、冠状位0.982、矢状位0.985;长轴长度ICC=0.989、短轴长度0.992、最小轴长度0.988(均P<.001)。

临床应用与阅片要点

  • 作者认为无对比剂MR成像可能适用于未治疗脑膜瘤的随访,可节省费用并规避对比剂相关风险。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND AND PURPOSE: Recent concerns relating to tissue deposition of gadolinium are favoring the use of noncontrast MR imaging whenever possible. The purpose of this study was to assess the necessity of gadolinium contrast for follow-up MR imaging of untreated intracranial meningiomas.

MATERIALS AND METHODS: One-hundred twenty-two patients (35 men, 87 women) with meningiomas who underwent brain MR imaging between May 2007 and May 2019 in our institution were included in this retrospective cohort study. We analyzed 132 meningiomas: 73 non-skull base (55%) versus 59 skull base (45%), 93 symptomatic (70%) versus 39 asymptomatic (30%). Fifty-nine meningiomas underwent an operation: 54 World Health Organization grade I (92%) and 5 World Health Organization grade II (8%). All meningiomas were segmented on T1 3D-gadolinium and 2D-T2WI. Agreement between T1 3D-gadolinium and 2D-T2WI segmentations was assessed by the intraclass correlation coefficient.

RESULTS: The mean time between MR images was 1485 days (range, 760-3810 days). There was excellent agreement between T1 3D-gadolinium and T2WI segmentations (P < .001): mean tumor volume (T1 3D-gadolinium: 9012.15 [SD, 19,223.03] mm3; T2WI: 8528.45 [SD, 18,368.18 ] mm3; intraclass correlation coefficient = 0.996), surface area (intraclass correlation coefficient = 0.989), surface/volume ratio (intraclass correlation coefficient = 0.924), maximum 3D diameter (intraclass correlation coefficient = 0.986), maximum 2D diameter in the axial (intraclass correlation coefficient = 0.990), coronal (intraclass correlation coefficient = 0.982), and sagittal planes (intraclass correlation coefficient = 0.985), major axis length (intraclass correlation coefficient = 0.989), minor axis length (intraclass correlation coefficient = 0.992), and least axis length (intraclass correlation coefficient = 0.988). Tumor growth also showed good agreement (P < .001), estimated as a mean of 461.87 [SD, 2704.1] mm3/year on T1 3D-gadolinium and 556.64 [SD, 2624.02 ] mm3/year on T2WI.

CONCLUSIONS: Our results show excellent agreement between the size and growth of meningiomas derived from T1 3D-gadolinium and 2D-T2WI, suggesting that the use of noncontrast MR imaging may be appropriate for the follow-up of untreated meningiomas, which would be cost-effective and avert risks associated with contrast media.

来源:AJNR Am J Neuroradiol,查看原文。版权归原作者所有。

引用

  1. Boto J, Guatta R, Fitsiori A, et al. Is Contrast Medium Really Needed for Follow-up MRI of Untreated Intracranial Meningiomas? AJNR Am J Neuroradiol. 2021. PMID: 34117017. doi:10.3174/ajnr.A7170

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。